ClinicalTrials.govpublic full text
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
urothelial carcinoma, carcinoma of the bladder, carcinoma of the urethra, carcinoma the of ureter, carcinoma of the renal pelvis, transitional cell carcinoma, transitional cell tumor, range, bladder cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829285
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.